Daily vitamin D supplementation significantly reduced type 2 diabetes risk by 19% in prediabetic individuals with specific genetic variations (AC or CC Apal gene variants), demonstrating a gene-specific response to the intervention.
This research highlights the potential for precision medicine in diabetes prevention, suggesting that genetic profiling could identify individuals who would most benefit from vitamin D supplementation, leading to more targeted and effective strategies.
While promising, the study cautions that high vitamin D levels needed for this effect might increase fall risk in older adults, emphasizing the need for careful risk-benefit assessment before widespread implementation of high-dose regimens.

Atlas AI
A recent study indicates that daily vitamin D supplementation may reduce the risk of developing type 2 diabetes by 19% in individuals with prediabetes who possess specific genetic variations. This effect was observed in participants with the AC or CC variants of the Apal vitamin D receptor gene.
Conversely, individuals with the AA variant of the same gene did not exhibit a similar reduction in diabetes risk when taking vitamin D supplements. This suggests a gene-specific response to vitamin D intervention.
These findings, if confirmed, could lead to more targeted preventative strategies for type 2 diabetes. The research highlights the potential for precision medicine approaches based on genetic profiling to optimize treatment efficacy and patient outcomes.
However, the study also notes that high vitamin D levels required for this effect might increase the risk of falls in older adults. This necessitates a careful assessment of risks and benefits for individual patients before implementing high-dose vitamin D regimens.
Genetic insights enhance precision in diabetes prevention globally
New research indicating that vitamin D supplementation reduces type 2 diabetes risk by 19% in prediabetics with specific genetic variations highlights the growing impact of precision medicine. This gene-specific response could lead to more targeted and effective global health strategies for diabetes prevention.

